Down 85%, Is There Any Hope for This Struggling Vaccine Stock?

Down 85%, Is There Any Hope for This Struggling Vaccine Stock?

In the early days of the pandemic, if there was one coronavirus vaccine stock investors were betting on, it was Novavax (NASDAQ: NVAX). The biotech stock soared more than 2,700% in 2020 as it developed its vaccine candidate. In the same timeframe, Pfizer shares hardly budged.